Exane was founded in 1990, on the back of a robust business model built around 3 fundamentals: the world of Equities, Investment and Research. Its expertise consistently wins strong recognition among clients as demonstrated in key investor surveys. 

Exane is specialised in two businesses: 
- Cash Equities: Research, execution, sale on European equities under the brand name BNP Paribas Exane;
- Structured Solutions: Exane Solutions has developed a complete range of products and services through different pillars: Derivatives Research, structured products, indices, smart execution.

Our 800 employees can now be found spread across 9 sites worldwide, with Paris and London as its main offices.

After a successful 17-year partnership with BNP Paribas, Exane became a subsidiary of BNP Paribas in July 2021.


Research

Exane

Pierre Séquier

Arnaud Giblat

Stephane B.

Richard Jones

Jason Hart

Amir Karimzada

Imad Eddine Radouane

Will Fairley

Yannick Stevant

Lionel Martin

Aurelie Marchetti

Nash Khan

Riaz Dad

Benjamin Aiach

Pascal Craplet

Naomi Nash

Stephane Menage

Frederic da Costa

Yoann Beatrix

Rakesh Ramani

Alex Evans

Robert Joynson

Harry Wyburd

Maurice Cohen

Joseph Hill

Declan Moore

Thomas Bourgeois

James Maher

Guillaume Lamand

Guilhem Grosso

Fabrice Lieske

William Packer

Phil Oshva

Paul Roger

Mark R.

The Sales and Trading Team at Exane is responsible for executing trades and providing expert sales support across various equity products and structured solutions. This diverse team specializes in cash equities and derivatives, leveraging their deep market knowledge to enhance client relationships and deliver tailored investment strategies. By facilitating seamless transactions and offering insightful market research, they play a crucial role in driving the company's success in the competitive financial landscape.

Sales and Trading Team

Equity Research Team

Leadership Team

Sales and Trading Team

About

Team members

Other teams at Exane

Equity Research Team

Leadership Team